SIGNAL
On August 31, Brandywine Realty Trust entered an agreement to sell its interest in 3151 Market Street, a 441,000-square-foot building in Philadelphia's Schuylkill Yards, for $240 million — $544 per square foot. The company's Form 8-K discloses that the property is 4% leased. A $57.3 million mortgage will be repaid at closing, and Brandywine expects net proceeds of approximately $168 million. The buyer delivered a $5 million non-refundable deposit, with closing scheduled for September 30, 2026.
The buyer is Burlington Stores, which is relocating its corporate headquarters from New Jersey. Burlington has committed a total of $370 million — the $240 million purchase plus $130 million of design and development — and will move 1,500 employees to Philadelphia while hiring roughly 500 more. All-in, that is $839 per square foot and about $185,000 of real estate per seat.
The building was underwritten as life sciences. Brandywine financed it in part with an $87.3 million C-PACE facility from Nuveen Green Capital, the largest such deal in Pennsylvania history when it closed in January 2026. It reached 4% leased. Nationally, CBRE put U.S. lab and R&D vacancy at a record 23.8% in Q1 2026, with asking rents down 8.1% year over year.
IMPLICATIONS — OUR READ
Compare the number to what institutional money paid this week for leased core office. Hamilton Square in Washington, D.C. — 278,000 square feet, 100% leased to IBM and GE — traded at $453 per square foot. Burlington paid 20% more per foot for a building that is 96% empty.
That inversion is the story. An investor buying 3151 Market would have priced it as a lease-up: discount the vacant floors, underwrite years of free rent and tenant improvements, demand a basis well below replacement cost. The vacancy would have been the single largest deduction in the model.
For Burlington it was the opposite. A corporate buyer solves for cost per employee, not yield on in-place income. It needs 441,000 square feet configured to its own specification, and an empty building is the only kind you can configure. Vacancy was not a discount factor — it was a feature the seller could not monetize and the buyer required.
The structure confirms the deal was negotiated rather than marketed. A 30-day window from agreement to scheduled closing, backed by non-refundable money, is not what a competitive process produces.
Stakeholder lens. For owners of large, empty, well-located buildings, the exit may not be an opportunistic fund at a distressed basis — it may be a corporation at a premium, triggered by a relocation decision that has nothing to do with your cap rate. For Brandywine, this is a clean recycle: roughly $168 million out of an asset that would not lease. For lenders holding paper on speculative life-sciences product, it is a reminder that the recovery value may sit outside the sector entirely. And for economic development officials, the arithmetic that moved 2,000 jobs across a state line was written in square feet.
KEY TAKEAWAY
When the buyer is the tenant, vacancy stops being a discount and becomes the reason the deal works.
Key Takeaways
When the buyer is the tenant, vacancy stops being a discount and becomes the reason the deal works
Burlington paid $544/sf for a 4%-leased building — 20% more than institutional capital paid this week for fully leased D.C. core at $453/sf
Investors solve for yield on in-place income; corporations solve for cost per seat — about $185,000 each across 2,000 jobs
A 30-day close backed by $5M of non-refundable money means this was negotiated, not marketed
Brandywine's life-sciences bet reached 4% leased against a record 23.8% national lab vacancy — and the recovery came from outside the sector
Neither party disclosed what Burlington will do with the C-PACE assessment, whether the 4% in-place tenancy survives, or what Brandywine's all-in development cost was — which is the number that would tell us whether $240 million is a recovery or a write-down. The sale is scheduled, not closed. Financing terms on Burlington's side are undisclosed.
Brandywine Realty Trust Form 8-K, SEC EDGAR, agreement dated Aug 31 2026; Philadelphia Inquirer, Sept 3–4 2026; CBRE U.S. Life Sciences Figures, Q1 2026; Nuveen Green Capital / Philadelphia C-PACE, January 2026; Hamilton Square comparison published by CRE360 Signal, Sept 4 2026; Per-foot and per-seat figures are CRE360 calculations from disclosed inputs
Get The Best Bid For Empty Office Came From Retail in your inbox
Burlington paid for a building that is 4% leased.
